|
Delivering Societal
Benefits:
Outcomes from the U.S. Advanced Technology Program
Slide 1:
Stephanie Shipp
Director
Economic Assessment Office, ATP
301 975-8978
sshipp@nist.gov | www.atp.nist.gov
Indiana University
April 22, 2003
Slide 2: Legislative Goals
".assisting United States businesses in creating and applying the generic
technology and research results to ---
(1) commercialize significant new scientific discoveries and technologies
rapidly; and
(2) refine manufacturing technologies”
Omnibus Trade and Competitiveness Act of 1988, Public Law
100-418
Slide 3: Outside Assessments
"The Committee finds that the Advanced Technology Program is an effective
federal partnership.its cost-shared, industry-driven approach to funding promising
new technological opportunities has shown considerable success in.improving
the efficiency and competitiveness of U.S. manufacturing"
-National Research Council
Board on Science, Technology, and Economic Policy
In “The Advanced Technology Program: Assessing Outcomes”
Slide 4: ATP Mission …
To accelerate the development of innovative technologies for broad
national benefit through partnerships with the private sector.
Slide
5: Key Features of the ATP
- Emphasis on innovation
for broad national economic benefit
- Industry leadership
in planning and implementing projects
- Project selection based
on technical and economic merit
- Demonstrated need for
ATP funding
- Requirement that projects
have well-defined goals/sunset provisions
- Project selection rigorously
competitive, based on peer review
- Program evaluation from
the outset
Slide 6: Addressing a National
Problem or Need
Evidence
- Federal funding plays a critical
role in crossing the Valley of Death
- ¨ATP represents a more important
element in bridging this gap than may have been appreciated
- VC, State Government and Universities
only contribute between 8 and 16% toward early stage technology development
- ¨ATP and SBIR account
for between 21 and 25%
Lewis
M. Branscomb
Aetna Professor of Public Policy
And Corporate Management, emeritus
Kennedy School of Government, Harvard University |
Philip
E. Auerswald
Assistant Director, Science,
Technology, and Public Policy Program
Kennedy School of Government, Harvard University |
Slide 7: Estimated distribution
of funding sources for early-stage technology development, based on restrictive
and inclusive criteria
Note: The proportional
distribution across the main funding sources for early-stage technology development
is similar regardless of the use of restrictive or inclusive definitional criteria.
Slide 8: Fourteen Years of Innovation
- Since 1990, 6,054
proposals submitted to 43 competitions, requesting $12,969 million from
ATP
- 709 projects awarded
with 1,433 participants and an equal number of subcontractors
- 207 joint ventures and
502 single companies
- $4,101 million of high-risk
research funded
ATP share = $2,114
million
Industry share = $1,987
million
- Small businesses are
thriving
65% of projects
led by small businesses
- Over 165 universities
participate
- Over 30 national
laboratories participate
Slide 9: Summary of Crosscutting
Findings
ATP Evaluation Toolkit Project
Considerable evidence that ATP is achieving its objectives:
- Increased rates of innovation
- Broadly enabling technology platforms
- Commercialization by U.S. companies
- Improved competitiveness of U.S.
industries
- Broadly distributed economic benefits
from large spillovers
- Increased collaborations
- Strong small business participation
- ATP a strong causal factor—leveraging,
not substituting
Slide 10: Two Major Criteria
Scientific
and Technological Merit
- Technical Rationale
- high technical risk &
feasibility
- technological innovation
- R&D Plan
Potential for Broad-Based
Economic Benefits
- National Economic Benefits
- Need for ATP Funding
- Pathway to Economic Benefits
Slide
11: ATP Projects Produce Large Benefits Benefits:
Net Social Benefits on 8 ATP projects:
| |
$16
Billion |
| Tissue
Engineering |
10.9
B |
| Component-Based
Software |
0.80
B |
| Refrigeration
|
0.45
B |
| Mammography
|
0.30
B |
| 2mm
Auto Body Consortium |
0.40
B |
| Data
Storage |
3.0
B |
| Printed
Wiring Board |
0.4
B |
| Flow
Control Machining |
0.14
B |
Slide 12: ATP Measures
Against Mission
Slide 13: ATP Project Outcomes
Identify goals that reflect program’s purpose
- Technical Publications: 747
- Patents: 800
- Technologies Commercialized:
195
300 projects completed
- 50% have technologies under commercialization
Slide 14: ATP Project Outcomes
ATP accelerates technology
development.
- 86% of project participants
report that they are ahead in their R&D cycle as a result of ATP funding
- Over half said that they
are ahead by 1 to 3 years
ATP fosters collaboration
- 85% of projects engaged
in collaborations with other companies, universities and federal labs
Slide 15: ATP Firms Commercialize
Technology
Technologies under commercialization--More
than 195 technologies under commercialization
- By end of ATP, 1 out
of 4 of projects commercialize an early application
- By 2-3 years after ATP,
1 out of 2 projects commercialize an early application
Most technologies begin
commercialization within 2-3 years after ATP
Slide 16: ATP Firms Commercialize
Technology
Different ATP-funded technologies
have different commercialization timelines
- Information Technology
applications earn revenues very quickly; 1 out of 3 begin during ATP
- Materials/Chemistry and
Manufacturing applications are the slowest to commercialize
- Biotechnologies have
some early applications but also late ones
Slide 17: ATP Projects
Lead to Spillover Benefits Spillover
benefits accrue to customers of ATP-funded technology
- 8 out of 10 companies
report that use of ATP technology reduces the customer’s costs of production
- 1 out of 2 report ‘very
significant’ reduction of the customer’s production costs
Slide 18: Example: Component-Based
Software Technology
- Component-Based Software
is a software production paradigm that focuses on building large software
systems from readily available components
- Projected benefits from
cluster of ATP projects
$1.5 billion on
combined public and private investment of $93 million
$10 in benefits
for every ATP $1 spent
Slide 19: Example: Low-Cost
Manufacturing Technology for Amorphous Silicon Detectors
- Digital mammography and
radiography systems are innovative technology solutions to the diagnostic
and productivity limitations of conventional X-ray
- The new process, expected
to be implemented by 2004, will reduce fabrication costs by approximately
25% without compromising performance:
Less complex fabrication
with fewer mask steps:
- 7 vs. 11
- Fewer total process
steps: 200 vs. 300
Slide 20: Low-Cost Manufacturing
Process Technology for Amorphous Silicon Detectors:
Applications in Digital Mammography and Radiography Benefits:
Broad societal benefits of digital mammography to medical facility users and
patients are much greater than the benefits to the companies that produce them
Societal benefits include:
- Increased throughput, reduced
patient examination time, and reduced waiting time
- Lower false positive rates, and
therefore fewer unnecessary biopsies
- Lower call-back rates for mammogram
under- and over exposure, and therefore avoidance of unnecessary procedures
- Reduced radiation exposure
- Simplified record retrieval and
record management of past mammograms
- Assistance in use of computer-aided
detection (CAD) for improved cancer detection
- Reduced
health disparities across population groups with greater use of telemammography
and teleradiology networks
Slide 21: Example: Low-Cost
Manufacturing Technology for Amorphous Silicon Detectors
Benefits:
- Additional digital mammography
and radiography systems are expected to be sold
- More patients will likely experience
the benefits of digital mammography and radiography
- More health-care facilities will
likely experience improved productivity and patient throughput
- $125 to 193
in benefits for every ATP $1 spent
Slide 22:
Ongoing Projects in Photonics
- Optoelectronics and Lasers
- Sensors, Metrology & Inspection
- Data Storage
- Displays & Imaging
- Lighting & Illumination
- Bio-photonics
- Nanotechnology and Materials
Slide 23:
In Summary … ATP
- Focuses on the civilian
sector
- Funds enabling technologies
with high spillover potential
- Focuses on overcoming
difficult research challenges
- Encourages company-university-laboratory
collaboration–capitalize on R&D investments
- Requires commercialization
plans and implementation to ensure societal outcomes
- Measures against mission
in their evaluation work
|
